A decade after Theranos, skeptics ask if AI diagnostics will be worse
krishnan · x · 2026-10-19
A new documentary on Elizabeth Holmes has revived discussion of Theranos. Commentator krishnan poses a pointed question: how many so-called AI-driven diagnostics and drug-discovery companies will end up being 10x, 20x, or even 100x Theranos? A Scientific American retrospective notes scientists exposed Theranos's false claims back in 2015 and worry such problems in science startups have only gotten worse.
More from AGI Musings
- Stanford's Noah Goodman Shares First-Pass AI Safety Concept Map for Lecture — noahdgoodman · 2026-10-19
- Agents may become the best distribution channel ever, argues VC on platform shifts — omooretweets · 2026-10-19
- Two Years On, the General LLM Bet Has Paid Off With No Wall in Sight — adivinemessenger · 2026-10-19
- Amazon blocks agentic commerce, JP Morgan blocks agentic banking — one agent will win — krishnan · 2026-10-19
- Kenney warns against AI slop; dev counters: AI is a tool for makers, not a substitute — majidmanzarpour · 2026-10-19
- Harvard's Boaz Barak opens AI safety course mocking OpenAI conflict of interest — zainhas · 2026-10-19